CVE-2014-6721
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509...
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
Exploit likelihood
What each source reports
NVD Score used
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
- Record
CVE-2014-6721- CVSS 2.0
- 5.4 Medium
AV:A/AC:M/Au:N/C:P/I:P/A:P - Weakness
- CWE-310
- Updated
- 2026-11-02
CVE List No score
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
- Record
CVE-2014-6721- Updated
- 2026-11-02
EUVDEUVD-2014-6599 No score
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
- Record
EUVD-2014-6599- Updated
- 2026-11-03
GitHub AdvisoriesGHSA-ggr2-rwrg-mjjf No score
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509...
The Pharmaguideline (aka com.pharmaguideline) application 1.2.0 for Android does not verify X.509 certificates from SSL servers, which allows man-in-the-middle attackers to spoof servers and obtain sensitive information via a crafted certificate.
- Record
GHSA-ggr2-rwrg-mjjf- Updated
- 2026-11-02
Affected products
Public exploits
Links only. Every CVE stores no exploit code.
| Source | Link | Date |
|---|---|---|
| PoC in GitHub | sagisar1/CVE-2014-6721-exploit-Shellshock | 2024-03-17 |
History
| Recorded | Changed | Sources |
|---|---|---|
| aliases | EUVD | |
| first indexed | CVE List, GitHub Advisories, NVD, PoC in GitHub |
Dates are when Every CVE recorded each change. Upstream dates may differ.
In short
CVE-2014-6721 is a medium vulnerability (CVSS 5.4) in Pharmaguideline, published September 26, 2014. Public exploit code exists. EPSS puts the chance of exploitation in the next 30 days at 0.66%, the 51st percentile. No source names a fixed version.